Clinical Trial

Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate

Study acronym: NBCA
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This randomized controlled trial investigates the safety and efficacy of injecting N-butyl-2- cyanoacrylate (Histoacryl®) into the pancreatic parenchyma during pancreaticoduodenectomy (PD) to enhance the security of the pancreaticojejunostomy (PJ) anastomosis and reduce postoperative pancreatic fistula (POPF) rates.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-13; most recent amendment 2025-11-30.
Status change: Not Yet Recruiting → Recruiting 2025-11-30
Trial Details
NCT Number NCT07230509
Lead Sponsor Minia University
Conditions Pancreaticoduodenectomy, Postoperative Pancreatic Fistula, Pancreas Cancer, Periampullary Cancer
Enrollment 90 participants
Start Date 2025-12-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-12-02